Astrocytes can be adjusted by neurons in response to injury and disease, a new study reports.
A new study reports the interaction between a mitochondrial protein called TOM20 and alpha-synuclein leads to neurodegeneration in Parkinson's disease.
Researchers have identified proteins in the blood that could reflect nerve cell damage.
Researchers identified LIPE, a lipase that degrades triglycerides to produce fatty acids, as a potential new target for the development of treatments for Parkinson's disease.
Mitochondrial CYP2D6 may be a powerful target for the treatment of Parkinson's disease induced by MPTP.
A Nature Neuroscience study reveals the normal role of alpha-synuclein, a protein implicated in Parkinson's disease. Researchers say understanding how the protein normally acts may give insights into how it might fail.
Researchers have developed a new tool which they say will help with the treatment and diagnosis of Parkinson's disease, especially in the early stages.
Researchers have developed a new method which nitrates alpha-synuclein to simulate the nitration patterns seen in PD.
Researchers have developed a new technique to quantify protein droplets associated with a range of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS.
A new, non-invasive technique appears to be able to improve Parkinson's disease symptoms in rats, researchers report.
Researchers have come up with a new, noninvasive method of stimulating areas deep within the brain by using electrodes placed on the scalp.
A new study sheds light on how ziram causes the loss of the main source of dopamine in the central nervous system.
